Repligen Corp
RGEN
ISIN null / Valor 965900
Repligen Corp
UMushroom community rating:
About company
Repligen Corp is a company that provides technology solutions for the development and manufacture of various biopharmaceutical products, including plasmid DNA, viral vectors, mRNA, and new modalities like whole cells and cultivated meat. With over 15 years of experience and a track record of successful implementation in commercial processes, Repligen's XCell® ATF Technology stands out as a scalable and efficient method for upstream intensification. Additionally, the company offers the CTech™ FlowVPX® spectrophotometer system, designed to meet regulatory GMP requirements by providing reliable real-time concentration measurements throughout the downstream process.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
10168 M
Market cap (USD)
1,177,804
Daily traded volume (Shares)
144.91 / 141.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
